======= RILP =======
== Gene Information ==
* **Official Symbol**: RILP
* **Official Name**: Rab interacting lysosomal protein
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83547|83547]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96NA2|Q96NA2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RILP&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RILP|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607848|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a lysosomal protein that interacts with RAB7, a small GTPase that controls transport to endocytic degradative compartments. Studies using mutant forms of the two proteins suggest that this protein represents a downstream effector for RAB7, and both proteins act together in the regulation of late endocytic traffic. A unique region of this protein has also been shown to be involved in the regulation of lysosomal morphology. [provided by RefSeq, Sep 2011].
* **UniProt Summary**: Rab effector playing a role in late endocytic transport to degradative compartments. Involved in the regulation of lysosomal morphology and distribution. Induces recruitment of dynein-dynactin motor complexes to Rab7A-containing late endosome and lysosome compartments. Promotes centripetal migration of phagosomes and the fusion of phagosomes with the late endosomes and lysosomes. {ECO:0000269|PubMed:11179213, ECO:0000269|PubMed:11696325, ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14668488}.
|Jnk-SapK ap N|
|RILP|
|intralumenal vesicle formation|
|regulation of multivesicular body size|
|regulation of endosome size|
|early endosome to late endosome transport|
|small GTPase binding|
|vesicle-mediated transport between endosomal compartments|
|endosome transport via multivesicular body sorting pathway|
|dynein light intermediate chain binding|
|multivesicular body sorting pathway|
|endosome to lysosome transport|
|phagocytic vesicle membrane|
|endosome organization|
|vesicle budding from membrane|
|antigen processing and presentation of exogenous peptide antigen via MHC class II|
|antigen processing and presentation of peptide antigen via MHC class II|
|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|
|lysosomal transport|
|late endosome membrane|
|late endosome|
|negative regulation of protein catabolic process|
|ciliary basal body|
|vacuolar transport|
|cytosolic transport|
|Rab GTPase binding|
|protein dimerization activity|
|antigen processing and presentation of exogenous peptide antigen|
|antigen processing and presentation of exogenous antigen|
|antigen processing and presentation of peptide antigen|
|antigen processing and presentation|
|positive regulation of protein catabolic process|
|endosomal transport|
|lysosome|
|vesicle organization|
|lysosomal membrane|
|negative regulation of catabolic process|
|cilium assembly|
|cilium organization|
|regulation of cellular component size|
|regulation of protein catabolic process|
|endomembrane system organization|
|positive regulation of catabolic process|
|plasma membrane bounded cell projection assembly|
|cell projection assembly|
|regulation of anatomical structure size|
|protein-containing complex|
|organelle assembly|
|membrane organization|
|regulation of catabolic process|
|negative regulation of protein metabolic process|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|protein transport|
|intracellular transport|
|peptide transport|
|amide transport|
|establishment of protein localization|
|positive regulation of protein metabolic process|
|establishment of localization in cell|
|nitrogen compound transport|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.82|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.01|
|[[:results:exp18|Doxycycline 10μM R00 exp18]]|2.62|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5797
* **Expression level (log2 read counts)**: 1.3
{{:chemogenomics:nalm6 dist.png?nolink |}}